Amid intense criticism, UnitedHealth Group reported a $29 billion increase in 2024 revenues today, up 8% to $400.3 billion.

Supply chain disruptions and inflation: A third of respondents identified supply chain disruptions and inflation as major ...

by Ishai Menache, Jeevan Pathuri, David Simchi-Levi and Tom Linton Companies face a variety of complex challenges in designing and optimizing their supply chains. Increasing their resilience ...

CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...

Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

2025 promises to be a tumultuous year for the American healthcare and pharma sector. Increased scrutiny on pricing and the ...